JNJ-75220795

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-75220795, covering 2025-03-30 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-75220795 in Japanese Participants [Phase 1]